It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
(Indirect) infringement, Antibodies, Extension of subject matter, Industrial application, United Kingdom
Further Success for HGS in the English Courts
-
Kluwer Christmas Quiz on Second Medical Use
-
USA: Microsoft Corporation v. Proxyconn, Inc, United States Court of Appeals, Federal Circuit, Nos. 2014-1542, 16 June 2015
-
Spain: The Court of Appeal of Barcelona (Section 15), Court of Appeal of Barcelona, 57/2017, 18 May 2017
-
Patent case: Oticon A/S and GN Resound A/S vs. Sivantos GmbH, EPO
-
Generics can be sued in the courts of the pharmacies, says the Court of Turin
-
Preparations for Unified Patent Court go on despite upcoming Brexit referendum
-
Paediatric extensions – Switzerland to follow suit as of January 2019
-
New policy for the Italian drugs agency on the disclosure of information on Gx applications
-
SMEs will need IP litigation insurance in Unitary Patent system